ERAS-0015

· Erasca, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ERAS-0015, covering 2025-09-11 to 2025-09-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors [Phase 1]